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2. Abstract  22 
MicroRNAs have emerged as essential regulators of beta-cell function and beta-cell 23 
proliferation. One of these microRNAs, miR-132, is highly induced in several obesity models 24 
and increased expression of miR-132 in vitro modulates glucose-stimulated insulin secretion. 25 
The aim of this study was to investigate the therapeutic benefits of miR-132 overexpression 26 
on beta-cell function in vivo. To overexpress miR-132 specifically in beta-cells, we employed 27 
adeno-associated virus (AAV8) mediated gene transfer using the rat insulin promoter in a 28 
double-stranded, self-complementary AAV vector to overexpress miR-132. Treatment of 29 
mice with dsAAV8-RIP-mir132 increased miR-132 expression in beta-cells without 30 
impacting expression of miR-212 or miR-375. Surprisingly, overexpression of miR-132 did 31 
not impact glucose homeostasis in chow fed animals. Overexpression of miR-132 did 32 
improve insulin secretion and hence glucose homeostasis in high-fat diet fed mice. 33 
Furthermore, miR-132 overexpression increased beta-cell proliferation in mice fed a high-fat 34 
diet. In conclusion, our data show that AAV8-mediated gene transfer of miR-132 to beta-cells 35 
improves beta-cell function in mice in response to a high fat diet. This suggests that increased 36 
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3. Introduction  42 
Decreased beta-cell function plays a pivotal role in the development of type 2 diabetes 43 
mellitus. Impaired beta-cell function is an early step in the course of type 2 diabetes mellitus, 44 
and the onset of beta-cell dysfunction seemingly occurs long before the development of 45 
hyperglycemia (Perley & Kipnis 1967; Kahn et al. 2001). MicroRNAs (miRNAs) are a 46 
recently discovered class of evolutionarily conserved short noncoding RNAs that regulate 47 
gene expression at a posttranscriptional level. MiRNAs bind with imperfect complementary 48 
to 3'-UTRs of target mRNAs, causing translational repression of the target gene or 49 
degradation of the target mRNA (Bartel 2004). MiRNAs are involved in a wide range of 50 
processes that includes development, apoptosis, proliferation, differentiation and regulation of 51 
metabolism. In beta-cells, miRNAs have emerged as essential regulators of beta-function, 52 
beta-cell proliferation and beta-cell survival (Poy et al. 2009; Latreille et al. 2014; Tattikota et 53 
al. 2014; Belgardt et al. 2015).  54 
Obesity, a major risk factor for type 2 diabetes mellitus, is known to change miRNA 55 
expression in islets (Zhao et al. 2009; Nesca et al. 2013). One of these miRNAs, miR-132, is 56 
of particular interest as expression of this miRNA is highly induced in islets of several obesity 57 
models (Zhao et al. 2009; Esguerra et al. 2011; Nesca et al. 2013). This obesity-related 58 
increased expression is severely reduced in diabetic-susceptible BTBR ob/ob mice (Zhao et al. 59 
2009). Overexpression of miR-132 in rodent beta cells in vitro results in enhanced glucose-60 
induced insulin secretion (Nesca et al. 2013; Soni et al. 2014). This study aims to investigate 61 
the therapeutic benefits of miR-132 overexpression on beta-cell function in vivo. In order to 62 
overexpress miR-132 specifically in beta-cells, we created an adeno-associated virus (AAV) 63 
vector containing miR-132 under control of the insulin promoter. AAV gene transfer has 64 
previously shown to efficiently and stably transduce beta-cells in vivo without impacting beta-65 
cell function (Wang et al. 2006; Montane et al. 2011). Subsequently, the impact of miR-132 66 
overexpression on beta-cell function was studied in mice under normal and insulin resistant 67 
conditions. 68 
  69 
Page 3 of 23 Accepted Manuscript published as JOE-18-0287.R2. Accepted for publication: 08-Oct-2018
Copyright © 2018 Society for Endocrinology Downloaded from Bioscientifica.com at 11/12/2018 08:22:29AM
via Bibliotheek der Rijksuniversiteit
  4
4. Material and Methods 70 
Generation of viral vectors The dsAAV8-RIP-GFP vector was constructed on the backbone 71 
of the dsAAV8 plasmid (Nathwani et al. 2006). The original LP1 promotor and FIX coding 72 
sequences were replaced by the rat insulin promotor (RIP) (Addgene Plasmid 15029) and 73 
enhanced green fluorescent protein (eGFP), by amplification using primers in table 1 and 74 
using MscI-BstXI and EcoRI-HindIII restriction sites. The gene encoding miR-132 was 75 
amplified from chromosomal DNA from C57Bl/6J mice, using primers listed in table 1 and 76 
cloned between the RIP and eGFP in dsAAV8-RIP-GFP, using the restriction enzymes BspEI 77 
and SbfI (New England Biolabs, Ipswich, MA, USA).  78 
 79 
AAV creation dsAAV viral particles were generated by triple transfection of human 80 
embryonic kidney 293 cells using the 25-kDa linear polyethylenimine (Polysciences Inc., 81 
Eppelheim, Germany) transfection method (Reed et al. 2006). AAV viral particles were 82 
purified by iodixanol gradient centrifugation as previously described (Zolotukhin et al. 1999). 83 
Viral titers were determined using quantitative PCR (qPCR) with primers specific for RIP and 84 
eGFP. 85 
 86 
Mice and in vivo virus injection Male C57Bl/6J wildtype, ob/ob and ob/+ mice (9-10 weeks) 87 
were obtained from the Harlan Laboratories. C57Bl/6J mice were injected with AAV at the 88 
age of 12 weeks. Intraductal injection was performed as described (Jimenez et al. 2011) with 89 
minor adjustments. Mice were anaesthetized with isoflurane. The duodenum was isolated 90 
with the common bile duct attached. A microclamp was placed on the bile duct caudal to the 91 
liver. Using a 27G needle, the duodenum was punctured after which the needle was inserted 92 
to advance retrograde through the sphincter of Oddi into the common bile duct. The needle 93 
was secured in place using a ligation and 100 µl PBS containing 1.4x1011 viral genome 94 
particles was injected into the duct over approximately 1 min. At 1 min post-injection the 95 
Page 4 of 23Accepted Manuscript published as JOE-18-0287.R2. Accepted for publication: 08-Oct-2018
Copyright © 2018 Society for Endocrinology Downloaded from Bioscientifica.com at 11/12/2018 08:22:29AM
via Bibliotheek der Rijksuniversiteit
  5
microclamps and needle were removed. The puncture in the duodenum was closed using 96 
tissue glue. Mice received buprenorphine (0.05 mg/kg s.c.) directly and 8 hours after surgery. 97 
Mice were allowed to recover for 2 weeks on chow diet (RMH-B, Hope Farms, Woerden, the 98 
Netherlands), after which mice received chow or high fat diet (60% kcal% fat diet, #D12492, 99 
Research Diets Inc., New Brunswick, USA) for 4 weeks. All experiments were performed 100 
with the approval of the Ethical Committee for Animal Experiments of the University of 101 
Groningen.  102 
Primary mouse islet isolation, cell culture and in vitro insulin secretion assay. Islets were 103 
isolated by collagenase digestion as previously described (Salvalaggio et al. 2002). Islets 104 
were rinsed and handpicked in RPMI media containing 10% FBS after which islets were 105 
frozen immediately for RNA isolation or cultured overnight. The following day, static insulin 106 
secretion assay was performed on size matched islets as previously described (Brunham et al. 107 
2007). Insulin was measured by ELISA (Mouse-Insulin Ultra Sensitive ELISA or the Rat 108 
Insulin ELISA, Alpco, Salem, NH, USA). Rat insulin-producing INS-1E cells (provided by 109 
Dr. P. Maechler, Centre Médical Universitaire, Geneva, Switzerland) were cultured as 110 
previously described (Merglen et al. 2004). INS-1E cells of passage numbers 50-60 were used 111 
in our experiments. For transfection, INS-1E cells were transfected using lipofectamine 2000 112 
(Invitrogen, Carlsbad, CA, USA) with miRNA mimics (Ambion, Life Technologies, Eugene, 113 
OR, USA). At 2 days after transfection, glucose stimulated insulin secretion was measured. 114 
To determine whether hyperglycemia would impact miR-132 expression levels, primary 115 
mouse islets were cultured for 24 hours in RPMI containing 2 mM, 8 mM or 16 mM glucose 116 
with 1% BSA with or without 0.4 mM palmitate (Sigma-Alrich, St. Louis, MO, USA).  117 
 118 
Glucose tolerance test and BrdU labeling Oral glucose tolerance tests were performed on 8-119 
hour fasted mice administered with 2 g glucose per kg of body weight. Blood was taken by 120 
the saphenous vain and blood glucose levels were measured using a glucometer and test strips 121 
(Life Scan). For plasma insulin levels, blood was collected using EDTA-coated capillary 122 
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tubes and insulin levels were measured by ELISA (Mouse-Insulin Ultra Sensitive ELISA, 123 
Alpco, Salem, NH, USA). For beta-cell proliferation measurements, mice were daily injected 124 
i.p. with 1 mg/animal BrdU (Sigma-Aldrich) in PBS for 4 days before sacrifice.  125 
 126 
Immunostaining and islet morphology analysis Formalin-fixed pancreatic tissues were 127 
embedded in paraffin using standard techniques. 4-µm sections were deparaffinized, 128 
rehydrated, and incubated with blocking solution. Sections were incubated overnight at 4°C 129 
with antibodies against insulin and glucagon (Dako, Glostrup, Denmark), GFP (Life 130 
Technologies, Eugene, OR, USA), and/or BrdU (Abcam, Cambridge, UK), followed by 131 
secondary antibodies conjugated to FITC or Cy3 (Life Technologies). DAPI-containing 132 
mounting media (Vector Laboratories, Burlingame, CA, USA) was added to coverslips. 133 
Proliferating beta cells were identified by co-staining for BrdU and insulin. All islets in 2 134 
pancreatic sections of 200 μm apart were analyzed, resulting in the counting of at least 573 135 
beta-cells/mouse with n = 4 mice per group. For beta cell area measurements, the percentage 136 
of insulin-positive area was determined using ImageScope (Aperio) from 5-6 evenly spaced 137 
sections per pancreas.  138 
 139 
Measurement of miRNA and mRNA expression Total RNA from isolated islets was isolated 140 
using the mirVana kit (Life Technologies) according to instructions. RNA quality and 141 
concentration was measured using the Bio-rad Experion Bioanalyzer and miRNA microarrays 142 
were run with miRNA microarrays (MirBase release 17.0) of Agilent (Santa Clara, CA, USA). 143 
Array images were analyzed using Agilent feature extraction software (10.7.3.1) and 144 
GeneSpring GX (Agilent). After quantile normalization, statistical significance was tested 145 
with an unpaired t test followed by Benjamini-Hochberg multiple testing correction [false 146 
discovery rate: 0.01 and a fold change of at least 2]. cDNA for miRNA expression 147 
measurements was synthesized using Taqman miRNA reverse transcription kit (Life 148 
Technologies). For mature miRNA transcript expression, we used Taqman miRNA Assays 149 
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(Life Technologies). cDNA for mRNA expression measurement was synthesized using 150 
Superscript II (Life Technologies). SYBR Green PCR Master Mix (Life Technologies) was 151 
used for RT-PCR in an ABI Prism 7700 Sequence Detection System. Expression values were 152 
normalized to GAPDH for mRNA and small nucleolar (sno) RNA202 for miRNA qRT-PCR.  153 
 154 
Protein analysis Isolated islets were lysed in M-PER lysis buffer (Thermo Fisher Scientific, 155 
USA). Proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane. 156 
The membrane was blocked using TBST with 2% milk and 0.5% BSA for 1hr at room 157 
temperature followed by incubation with the primary antibodies in TBST with 0.5% BSA for 158 
2 hours. Primary antibodies used were anti-retinoblastoma (Santa Cruz Biotechnology), anti-159 
Cact (Novus Biologicals), anti-actin (Sigma Aldrich) and anti-Gapdh (Milipore). After 160 
probing with the primary antibodies, the membrane was incubated with HRP-conjugated 161 
secondary antibodies (rabbit-anti-mouse HRP conjugated, or goat-anti-rabbit HRP conjugated, 162 
Dako, Denmark). Chemilunimescence was determined using SuperSignal West Dura 163 
Extended Duration Substrate buffer (Thermo Fisher Scientific) and Chemidoc (Biorad, USA).  164 
 165 
Statistical Analysis Graphpad Prism 6.0 was used for statistical analysis. Data are presented as 166 
Tukey’s Box-and-Whiskers plot using median and 25th and 75th percentile intervals (P25-P75). 167 
Differences between groups were calculated by Mann-Whitney test with a P value of 0.05 168 
considered significant. A two-way ANOVA, followed by Bonferroni posthoc tests, was used 169 
to evaluate the glucose tolerance tests.  170 
 171 
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5. Results 173 
Leptin deficiency resulted in profound differences in miRNA profiles of ob/ob islets, with 36 174 
miRNAs increased and 36 miRNAs decreased by >2 fold compared to control islets (n=6, 175 
FDR<1%). MiR-132 was one of the most induced miRNAs in ob/ob islets with a fold change 176 
of 6.2 (Fig 1A). Using RT-PCR, we showed increased expression of miR-132 in islets of 177 
ob/ob mice, high fat fed mice and 14-month aged mice (Fig 1B). As all the diabetic/insulin 178 
resistant models tested had elevated fasting blood glucose levels, we determined whether 179 
hyperglycemia itself regulated expression of miR-132. Indeed, miR-132 expression levels 180 
were upregulated by culturing primary mouse islets in 16 mM glucose for 24 hours. This 181 
increase was augmented by the addition of 2 mM palmitate (Fig 1C). In agreement with 182 
previous data (Nesca et al. 2013; Soni et al. 2014), overexpression of miR-132 in INS1E cells 183 
resulted in increased glucose-stimulated insulin secretion (Fig 1D). Together these results 184 
confirm previous data showing a role for miR-132 in glucose-regulated insulin secretion in 185 
beta cells in vitro. 186 
 187 
Increased miR-132 expression result in improved insulin secretion during high fat 188 
feeding 189 
To determine whether increased expression of miR-132 would increase insulin secretion in 190 
vivo, we created double stranded adeno-associated virus serotype 8 (dsAAV8) vectors 191 
containing mouse miR-132 and GFP cDNA or GFP cDNA driven by the rat insulin promoter 192 
(AAV8-RIP-mir132 and AAV8-RIP-GFP). Injection of the constructs in the pancreatic duct 193 
resulted in GFP expression specifically in β-cells in the islet (Fig 2A). Based on the GFP, the 194 
proportion of islets with GFP positive cells was relatively high; 77±15 % for control and 195 
88±5% for AAV-RIP-miR132 treated mice. Increased expression of miR-132 was detected in 196 
isolated islets of AAV-RIP-miR132 injected animals, confirming miR-132 overexpression in 197 
β-cells in vivo (Fig 2B). Histological examination of the pancreata of the mice showed no 198 
evidence of pancreatitis or fibrosis. Islets of both groups displayed normal morphology with 199 
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the β-cells in the core and the α-cells at the rim of the islet (Fig 2E).  200 
Therapeutic overexpression of miRNAs could potentially modify the processing of other 201 
cellular miRNAs transcripts due to the same processing pathways (Grimm et al. 2006). 202 
Therefore, we tested the expression of miR-375, a microRNA highly expressed in beta cells 203 
and involved in regulation of insulin secretion (Poy et al. 2004) and miR-184, a modulator of 204 
compensatory beta cell expansion during insulin resistance (Tattikota et al. 2014). To exclude 205 
a possible negative feedback loop due to miR-132 overexpression on the miR-132/miR-212 206 
cluster, miR-212 levels were determined in the islets of control and miR-132 treated mice. 207 
Overexpression of miR-132 did not impact expression of miR-212, miR-375 or miR-184 (Fig 208 
2C), indicating that overexpression of miR-132 did not interfere with the processing of other 209 
microRNAs.  210 
After initial weight loss in the first week after the injection, all mice gained weight 1 month 211 
after the injection (Fig 3A) after which glucose homeostasis was analyzed. Surprisingly, 212 
overexpression of miR-132 did not impact fasted glucose or insulin plasma levels. In addition, 213 
glucose tolerance testing showed no difference in glucose control between the animals (Fig 214 
3B,C). To increase the demand on beta cells, mice were put on a high fat diet for 4 weeks. In 215 
the control AAV-RIP-GFP treated mice, high fat diet increased fasted glucose levels and 216 
impaired glucose tolerance (Fig 3D). Overexpression of miR-132 specifically in beta cells, 217 
however, resulted in improved glucose tolerance compared to control mice. This was due to 218 
increased glucose-stimulated insulin secretion as measured during the glucose tolerance test 219 
(Fig 3E) and ex vivo in isolated islets (Fig 3F). Insulin content of isolated islets was similar in 220 
control and AAV-RIP-miR132 treated mice (0.37±0.04 µg/islet in control islets vs. 0.33±0.04 221 
µg/islet in miR-132 islets; n=6). In addition, gene expressions of genes related to insulin 222 
secretion or beta-cell function, such as insulin, glucose transporter 2 (Glut2), prohormone 223 
convertase 2 (Psck2), MAF bZIP transcription factor A  (Mafa) or pancreatic and duodenal 224 
homeobox 1 (Pdx1) were similar between groups (Fig 3G). Gene expression and protein 225 
levels of the miR-132 target carnitine acyl-carnitine translocase (Cact) (Soni et al. 2014) was 226 
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decreased in islets of AAV-RIP-miR132 injected animals (Fig 3H). 227 
 228 
Increased beta cell proliferation in mice overexpressing mir-132  229 
Overexpression of miR-132 in dispersed rat islet cells has been shown to increase beta-cell 230 
proliferation in vitro (Nesca et al. 2013). In order to determine whether overexpression of 231 
miR-132 in vivo also lead to increased beta cell proliferation, beta cell proliferation was 232 
studied in the AAV-RIP-miR132 and control mice after 2 weeks of high fat diet feeding using 233 
BrdU incorporation. Overexpression of miR-132 lead to 2.4-fold increase in BrdU+ beta cell 234 
(Fig 4A,B). In agreement with this, we found increased expression levels of the proliferation 235 
marker Ki67 in isolated islets from AAV-RIP-miR132 mice fed a high fat diet for 4 weeks 236 
(Fig 4C). Although, gene expression levels of the previously identified miR-132 target 237 
retinoblastoma protein (Rb) (Park et al. 2011) were similar in both groups (1.0±0.5  relative 238 
expression in control islets vs. 1.2±0.3 relative expression in miR-132 islets; p=0.48), protein 239 
analysis revealed decreased Rb protein levels in islets of miR-132 treated mice (Fig 4 D). To 240 
determine whether the increased proliferation resulted in increased beta cell mass, beta cell 241 
area was analysed. However, the beta cell area did not significantly differ between the groups 242 
(0.84±0.29% beta cell area in control islets vs. 1.18±0.38 % beta cell area in miR-132 islets; 243 
n=4; p=0.2). 244 
 245 
  246 
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6. Discussion 247 
Our data show that AAV8-mediated gene transfer of miR-132 to beta cells improves beta cell 248 
function in mice in response to a high fat diet. We found significant increased glucose-249 
stimulated insulin secretion and enhanced beta cell proliferation in mice treated with the 250 
dsAAV8-RIP-miR132 construct. These data indicate that miR-132 is a potential target to 251 
improve beta cell dysfunction during obesity.  252 
Although, overexpression of miR-132 improves insulin secretion in vitro, mice glucose 253 
homeostasis remained unaltered in chow-fed mice overexpressing miR-132 indicating that the 254 
risk on hypoglycaemia is low. Mice treated with dsAAV-RIP-miR132, however, did show 255 
improved insulin secretion during high fat diet feeding. Recent findings identified Cact as 256 
miR-132 target in beta cells (Soni et al. 2014). Cact is a transporter involved in transporting 257 
long-chain acyl-carnitines into the mitochondria for β-oxidation (Wang et al. 2011). 258 
Downregulation of Cact results in an accumulation of fatty acyl-carnitines, which enhances 259 
insulin secretion.  Addition of long-chain acyl-carnitines to beta cells stimulated insulin 260 
secretion; an effect that was enhanced by Cact downregulation (Soni et al. 2014). This could 261 
explain our finding that only during increased fatty acid influx, as achieved by the high fat 262 
diet, insulin secretion was increased in the miR-132 overexpressing beta cells.  263 
In this study we chose to apply beta cell specific gene therapy to evade possible side effects of 264 
miR-132 overexpression in non-beta cells. MiR-132 has previously found to be involved in 265 
facilitating pathological angiogenesis in tumors (Anand et al. 2010) and is over-expressed in 266 
pancreatic adenocarcinomas (Park et al. 2011). In the pancreatic cancer cell line PAN-1, 267 
overexpression of miR-132 leads to decreased expression of the tumor suppressor Rb, leading 268 
to increased proliferation (Park et al. 2011). No difference in expression of Rb mRNA in 269 
islets of dsAAV8-RIP-miR132 treated mice was found, which could be due to the relative 270 
high gene expression of Rb in alpha cells compared to beta cells (Kutlu et al. 2009). Protein 271 
levels of Rb, however, were decreased in islets overexpressing MiR-132. Interestingly, 272 
exendin-4, a GLP-1 agonist known to induce beta cell proliferation in mice, has been shown 273 
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to decrease Rb expression. Further study revealed that this decreased Rb expression is 274 
necessary for the beta cell proliferation stimulating effect of excendin-4 (Cai et al. 2014). 275 
GLP-1 agonists increase miR-132 expression in beta cells (Shang et al. 2015), suggesting that 276 
miR-132 plays an central role in the adaptive beta cell response to obesity and GLP-1. 277 
Although we found increased BrdU incorporation and increased Ki67 expression in islets of 278 
dsAAV8-RIP-miR132 treated mice after high fat feeding indicating increased beta cell 279 
proliferation, beta cell area was not significantly different between the groups. The high 280 
variation in beta-cell area within the groups, the small group size and the relatively short 281 
period of high fat diet could potentially explain this discrepancy.  282 
Unfortunately, it was not possible to identify miR-132 targets in our setting due to the 283 
difficulty to isolate pure beta cells together with the fact that miRNAs often induce only small 284 
changes in the expression of single direct targets (Guo et al. 2010). However, our study does 285 
show that the physiological impact of miRNAs in beta cells can be successfully studied in 286 
vivo using the AAV8-mediated gene transfer system. This system could potentially help to 287 
identify the physiological roles of the over 800 miRNAs which recent ultra-high-throughput 288 
sequencing have revealed to be expressed in the endocrine pancreas (Kameswaran et al. 289 
2014).  290 
During the last years, the importance of microRNAs in the control of beta cell function, 291 
proliferation and identity has become clear. Several microRNAs, such as, miR-375 and miR-292 
184 have been identified as crucial regulators of adaptive beta cell expansion, whereas miR-293 
7a regulates insulin secretion. Our study shows the beneficial effects of miR-132 294 
overexpression in the setting of obesity and identifies miR-132 or its downstream targets as 295 
therapeutic targets to improve beta cell function.  296 
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 Figure legends 1 
 2 
Figure 1. Hyperglycemia and obesity induced miR-132 expression resulting in increased 3 
insulin secretion. A. Several miRNAs were differently expressed in pancreatic islets of 12 4 
week old ob/ob mice (n=6).  B. Increased miR-132 expression in islets isolated from ob/ob 5 
(n= 4), 10 week high diet-fed C57Bl6 mice (n=4) or 14 month old C57Bl6 mice (n=7-8). C. 6 
Culture of primary islet for 24 hours in high glucose media or media containing 2 mM 7 
palmitate induced miR-132 expression (n=4). D. Overexpression of miR-132 in INS1E cells 8 
resulted in increased glucose-stimulated insulin secretion (n=4).  9 
 10 
Figure 2. AAV8 mediated gene transfer resulted in miR-132 overexpression in beta cells.  11 
A. Representative image of immunofluorescent staining against GFP (green) and insulin (red) 12 
in control AAV-RIP-GFP or AAV8-RIP-miR132 treated mice. B. Increased expression of 13 
miR-132 in islets isolated from AAV8-RIP-miR132 treated mice compared to islets isolated 14 
from control mice (n=4-6). C. Expression of miR-375, miR-184 and miR-212 in islets was 15 
comparable between AAV8-RIP-miR132 treated and control mice (n=4-6). D. Representative 16 
image of islet morphology based immunofluorescent staining against insulin (green) and 17 
glucagon (red). 18 
 19 
Figure 3. Impact of miR-132 overexpression in beta cells on glucose homeostasis. A. Body 20 
weights of AAV8-RIP-GFP control and AAV8-RIP-miR132 treated mice (n=6) during chow 21 
and high fat diet (HFD) feeding. B. AAV8-RIP-miR132 treated mice showed similar glucose 22 
levels during fasting or after oral glucose bolus as control mice fed a chow diet (n=6). C. 23 
Insulin levels at 0 and 15 minutes after oral glucose bolus were similar between the 2 groups 24 
(n=6). D. Oral glucose tolerance testing showed improved glucose tolerance in AAV8-RIP-25 
miR-132 treated mice after 4 weeks of high fat diet (n=6). E. Analysis of insulin levels at 0 26 
and 15 minutes after oral glucose bolus showed increased insulin secretion in mice 27 
overexpressing miR-132 after the glucose bolus (n=6). F. Ex vivo analysis of glucose-28 
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stimulated insulin secretion showed increased insulin secretion at 16.7 mM glucose in miR-29 
132 overexpressing islets (n=6). G. Isolated islets of AAV8-RIP-miR132 treated mice showed 30 
normal gene expression of beta-cell related genes (n=4-6). H. Increased expression of miR-31 
132 coincided with reduced expression of CACT mRNA and protein levels (n=4-6).  32 
 33 
Figure 4. Signs of increased proliferation in beta cells of AAV8-RIP-miR132 treated 34 
mice. A. Pancreatic sections of control or AAV8-RIP-miR-132 treated mice stained using 35 
immunofluorescence for insulin (green) and BrdU (red). B. Percentage of BrdU positive beta 36 
cells in pancreata of control and AAV8-RIP-miR-132 mice (n=4). C. Isolated islets of AAV8-37 
RIP-miR132 treated mice showed increased Ki67 gene expression (n=4-6). D. Decreased Rb 38 
protein levels in isolated islets of AAV8-RIP-miR132 treated mice, of which the 39 
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13. Tables 
Table 1: Primer sequences 
Primer Name Sequence  Gene 
scAAV-GFP-fw tactacgaattcaccatggtgagcaagggcgag GFP 
scAAV-GFP-rv tactacaagctttcacttgtacagctcgtcca GFP 
scAAV-RIP-fw gtggagtcgtcgtaccgggccc RIP 
scAAV-RIP-rv gttgccaggtcagtgggcatgcctgc RIP 
Mmu-mir132-fw gcgaaacctgcaggtccctgcgccgctgtccgcg Mmu-mir132 
Mmu-mir132-rv gcgaaatccggatgccacctccgcagacacat Mmu-mir132 
Page 23 of 23 Accepted Manuscript published as JOE-18-0287.R2. Accepted for publication: 08-Oct-2018
Copyright © 2018 Society for Endocrinology Downloaded from Bioscientifica.com at 11/12/2018 08:22:29AM
via Bibliotheek der Rijksuniversiteit
